Anales de la RANM

18 A N A L E S R A N M R E V I S T A F U N D A D A E N 1 8 7 9 PREVENCIÓN DE RADIODERMITIS Ana C. Fernández-Tresguerres Centeno Año 2018 · número 135 (01) · páginas 13 a 19 duced free radical formation in skin: an electron paramagnetec resonance study. Photochem Pho- tobiol 1994; 59: 1-4 18. Bangha E, Elsner P, Kistler GS. Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptami- ne). A dose response study. Arch Dermatol Res 1996;288:522-526 19. Bangha E, Elsner P, Kistler GS. Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). In- fluence of the aplication time point. Dermatol. 1997;197:248-252 20. Tresguerres AF. Efecto de tratamientos hormo- nales crónicos sobre el envejecimiento cutáneo. Tesis doctoral, Facultad de Medicina de la Uni- versidad Complutense de Madrid 2006 21. López A, Aréchiga CF, Bañuelos R, Barbosa OY, Sánchez SH, Lazarova Z. Impacto del estrés oxi- dativo sobre las lesiones cutáneas causadas por radiaciones ionizantes. Mem Inst Investig Cienc Salud 2012; 10(1):89-99 22. Shirazi A, Ghobadi G and Ghazi-Khansari M. A radiobiological Review on Melatonin: a novel ra- dioprotector. J. Radiat. Res. 2007; 48:2063-2072 23. Fuchs E. Scratching the surface of skin develop- ment. Nature 2007; 445 (7130): 83442 24. Zhao W, Diz DI, Robbins ME. Oxidative damage pathways in relation to normal tissue injury. Br J Radiol 2007; 80 (1):S23-31 25. Allegra M, Reiter RJ, Tan DX, Gentile C, Tesorie- re L, Livrea MA. The chemistry of melatonin’s interaction with reactive species. J Pineal Res 2003; 20:921-962 26. Tan DX, Reiter RJ, Manchester LC et al. Chemi- cal and physical properties and potential mecha- nisms: melatonin as a broad spectrum antioxi- dant and free radical scavener. Curr Top Med Chem 2002; 2: 181-197 27. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ. One molecule, many derivatives: a never-ending interaction of melatonin with re- active oxygen and nitrogen species. J Pineal Res 2007; 42:28-42 28. Fischer TW, Scholz G, Knöll B, Hipler UC, Els- ner P. Melatonin suppresses reactive oxygen spe- cies in UV-irradiated leukocytes more tan Vit C and trelox. Skin Pharmacol Appl Skin Physiol 2002; 15:367-373 29. Fischer TW, Scholz G, Knöll B, Hipler UC, Els- ner P. Melatonin suppresses reactive oxygen spe- cies induced by UV irradiation in leukocytes. J Pineal Res 2004; 37: 107-112 30. Reiter RJ, Poeggeler B, Tan DX, Chen LD, Man- chester LC, Guerrero JM. Antioxidant capacity of melatonin: a novel action not requiring a re- ceptor. Neuroendocrinol Lett 1993; 15:103-116 31. Lee BJ, Parrott KA, Ayres JW, SacK RL. Prelimi- nary evaluation of transdermal delivery of me- latonin in human subjects. Res Commun Mol Pathol Pharmacol 1994; 85:337-346 32. Lee KS, Lee WS, Suh SI et al. Melatonin reduces UVB induced cell damages and polyamine levels in human skin fibroblasts in cultura. Exp Mol Med 2003; 35:263-268 33. Ryoo YW, Suh SI, Mun KC,Kim BC, Lee KS. The effects of the melatonin on UVB irradiated cul- tured dermal fibroblasts. J Dermatol Sci 2001; 27: 162-169 34. Fischer TW, Zbytek B, Sayre RM, Apostolov EO, Basnakian AG, Sweatman TW, et al. Melatonin increases survival of HaCaT keratinocytes by suppressing UV-induced apoptosis. J Pineal Res 2006; 40:18-26 35. Fischer TW, Zmijewski MA, Worstman J, Slom- inski A. Melatonin mantains mitocondrial mem- brane potential and attenuates activation of ini- tiator (caspasa 9) and effector caspases (casp-3/ casp-7) and PARP in UVR-exposed HaCaT kera- tinocytes. J Pineal Res 2008; 44:397-407 36. Hussein MR, Abu-Dief EE, Abd El-Reheem MH, Abd-Elrahman A. Ultrastructural evaluation of the radioprotective effects of melatonin against X-ray-induced skin damage in Albino rats. Int J Exp Pathol 2005; 86:45-55 37. Sener G, Atasoy BM, Ersoy Y, Arbak S, Sengoz M, Yegen BC. Melatonin protects against ioni- zing radiation-induced oxidative damage in cor- pus cavernosum and urinary bladder in rats. J Pineal Res 2004;37:241-246 38. Vasin MV, Ushakov IB, Kovtun V, Komarova SN, Semenova LA, Galkin AA. Evaluation of skin sensitization potential of melatonin and nime- sulide by murine local lymph node assay. Radiat Biol Radioecol 2004;44:68-71 39. Kim BC, Shon BS, Ryoo YW, Kim SP, Lee KS. Melatonin reduces X-ray irradiation-induced oxidative damages in cultured human skin fibro- blasts. J Dermatol Sci 2001;26:194-200 40. Kilanczyk E, Bryszewska M. The effect of mela- tonin on antioxidant enzymes in human diabetic skin fibroblasts. Cell Mol Biol Lett 2003;8:333- 336 41. Lissoni P, Malugani F, Malysheva O, et al. Neu- roimmunotherapy of untreatable metastatic so- lid tumors with subcutaneous low-dose interleu- kin-2, melatonin and naltrexone: modulation of interleukin-2-induced antitumor immunity by blocking the opioid system. Neuroendocrinol Lett 2002;23:341-344 42. Lissoni P, Vaghi M, Ardizzoia A, et al. A pha- se II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone melatonin (P.I.M.) as a second-line therapy in metastatic melanoma patients progressing on dacarbazine plus interfe- ron-alpha. In Vivo 2002;16:93-96 43. Blask DE, Sauer LA and Dauchy RT. Melatonin as a Chronobiotic/Anticancer Agent: celular, biochemical, and molecular Mechanisms of ac- tion and their implicantions for circadian-based cáncer therapy. Curr Top in Med Chem. 2002; 2:113-132 44. Cos S, Mediavilla MD, Fernández R, González- Lamuno D Sánchez-Barcelo EJD. Melatonin in- duce apoptosis in MCF-7 human breast cancerl cells in vitro . J Pineal Res 2002; 32:90-94 45. Manda K and Bhatia AL. Melatonin-induced re- duction in age-related accumulation of oxidative damage in mice. Biogerontology 2003;4:133-139 46. Fischer TW, Elsner P. The antioxidative potential of melatonin in the skin. Curr Probl Dermatol 2001;29:165-174 47. Fischer TW, ELsner P. Melatonin: a hormone,